Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I2PP2A) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau

Abnormal hyperphosphorylation of Tau leads to the formation of neurofibrillary tangles, a hallmark of Alzheimer disease (AD), and related tauopathies. The phosphorylation of Tau is regulated by protein phosphatase 2A (PP2A), which in turn is modulated by endogenous inhibitor 2 (I2PP2A). In AD brain,...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 2014-10, Vol.289 (40), p.27677-27691
Hauptverfasser: Arif, Mohammad, Wei, Jianshe, Zhang, Qi, Liu, Fei, Basurto-Islas, Gustavo, Grundke-Iqbal, Inge, Iqbal, Khalid
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 27691
container_issue 40
container_start_page 27677
container_title The Journal of biological chemistry
container_volume 289
creator Arif, Mohammad
Wei, Jianshe
Zhang, Qi
Liu, Fei
Basurto-Islas, Gustavo
Grundke-Iqbal, Inge
Iqbal, Khalid
description Abnormal hyperphosphorylation of Tau leads to the formation of neurofibrillary tangles, a hallmark of Alzheimer disease (AD), and related tauopathies. The phosphorylation of Tau is regulated by protein phosphatase 2A (PP2A), which in turn is modulated by endogenous inhibitor 2 (I2PP2A). In AD brain, I2PP2A is translocated from neuronal nucleus to cytoplasm, where it inhibits PP2A activity and promotes abnormal phosphorylation of Tau. Here we describe the identification of a potential nuclear localization signal (NLS) in the C-terminal region of I2PP2A containing a conserved basic motif, 179RKR181, which is sufficient for directing its nuclear localization. The current study further presents an inducible cell model (Tet-Off system) of AD-type abnormal hyperphosphorylation of Tau by expressing I2PP2A in which the NLS was inactivated by 179RKR181 → AAA along with 168KR169 → AA mutations. In this model, the mutant NLS (mNLS)-I2PP2A (I2PP2AAA-AAA) was retained in the cell cytoplasm, where it physically interacted with PP2A and inhibited its activity. Inhibition of PP2A was associated with the abnormal hyperphosphorylation of Tau, which resulted in microtubule network instability and neurite outgrowth impairment. Expression of mNLS-I2PP2A activated CAMKII and GSK-3β, which are Tau kinases regulated by PP2A. The immunoprecipitation experiments showed the direct interaction of I2PP2A with PP2A and GSK-3β but not with CAMKII. Thus, the cell model provides insights into the nature of the potential NLS and the mechanistic relationship between I2PP2A-induced inhibition of PP2A and hyperphosphorylation of Tau that can be utilized to develop drugs preventing Tau pathology.
doi_str_mv 10.1074/jbc.M114.565358
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4183805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925820484042</els_id><sourcerecordid>1586101080</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-2a29d170cd6ecafa6dd09a97da00cabc4569c504700ce86b51e793b8992952f23</originalsourceid><addsrcrecordid>eNp1kcFv1SAcx4nRuOf07M1wnIe-AS1tuZg0L9O9ZGYvZkt2I5T-apm0VKBLnif_dJlvW_QwLgT48P3B74PQe0rWlFTF6W2r118pLda85DmvX6AVJXWe5ZzevEQrQhjNBOP1EXoTwi1JoxD0NTpinLKas3KFfm_20c1WhdFo_A0iTNG4Cbse77yLYCa8G1yYBxVVAMwavJ0G05roPGb4ZMt2O9Z8TJvdoiHgxv4awIzgM2t-AG7ayflRWXy-n8HPf4Oc31v1WONKLW_Rq17ZAO8e5mN0_fnsanOeXVx-2W6ai0xzImLGFBMdrYjuStCqV2XXEaFE1SlCtGp1wUuRyKJKS6jLllOoRN7WQjDBWc_yY_TpkDsv7QidTh_1ysrZm1H5vXTKyP9PJjPI7-5OFrTOa8JTwMlDgHc_FwhRjiZosFZN4JYgKa9LSlL7SUJPD6j2LgQP_VMZSuS9N5m8yXtv8uAt3fjw7-ue-EdRCRAHAFKP7gx4GbSBSUNnPOgoO2eeDf8DqKipRQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1586101080</pqid></control><display><type>article</type><title>Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I2PP2A) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Arif, Mohammad ; Wei, Jianshe ; Zhang, Qi ; Liu, Fei ; Basurto-Islas, Gustavo ; Grundke-Iqbal, Inge ; Iqbal, Khalid</creator><creatorcontrib>Arif, Mohammad ; Wei, Jianshe ; Zhang, Qi ; Liu, Fei ; Basurto-Islas, Gustavo ; Grundke-Iqbal, Inge ; Iqbal, Khalid</creatorcontrib><description>Abnormal hyperphosphorylation of Tau leads to the formation of neurofibrillary tangles, a hallmark of Alzheimer disease (AD), and related tauopathies. The phosphorylation of Tau is regulated by protein phosphatase 2A (PP2A), which in turn is modulated by endogenous inhibitor 2 (I2PP2A). In AD brain, I2PP2A is translocated from neuronal nucleus to cytoplasm, where it inhibits PP2A activity and promotes abnormal phosphorylation of Tau. Here we describe the identification of a potential nuclear localization signal (NLS) in the C-terminal region of I2PP2A containing a conserved basic motif, 179RKR181, which is sufficient for directing its nuclear localization. The current study further presents an inducible cell model (Tet-Off system) of AD-type abnormal hyperphosphorylation of Tau by expressing I2PP2A in which the NLS was inactivated by 179RKR181 → AAA along with 168KR169 → AA mutations. In this model, the mutant NLS (mNLS)-I2PP2A (I2PP2AAA-AAA) was retained in the cell cytoplasm, where it physically interacted with PP2A and inhibited its activity. Inhibition of PP2A was associated with the abnormal hyperphosphorylation of Tau, which resulted in microtubule network instability and neurite outgrowth impairment. Expression of mNLS-I2PP2A activated CAMKII and GSK-3β, which are Tau kinases regulated by PP2A. The immunoprecipitation experiments showed the direct interaction of I2PP2A with PP2A and GSK-3β but not with CAMKII. Thus, the cell model provides insights into the nature of the potential NLS and the mechanistic relationship between I2PP2A-induced inhibition of PP2A and hyperphosphorylation of Tau that can be utilized to develop drugs preventing Tau pathology.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.M114.565358</identifier><identifier>PMID: 25128526</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alzheimer Disease - genetics ; Alzheimer Disease - metabolism ; Brain - metabolism ; Cell Nucleus - metabolism ; Cytoplasm - genetics ; Cytoplasm - metabolism ; DNA-Binding Proteins ; Glycogen Synthase Kinase 3 - genetics ; Glycogen Synthase Kinase 3 - metabolism ; Glycogen Synthase Kinase 3 beta ; Histone Chaperones - genetics ; Histone Chaperones - metabolism ; Humans ; Neurobiology ; Nuclear Localization Signals ; Phosphorylation ; Protein Phosphatase 2 - genetics ; Protein Phosphatase 2 - metabolism ; tau Proteins - genetics ; tau Proteins - metabolism ; Transcription Factors - genetics ; Transcription Factors - metabolism</subject><ispartof>The Journal of biological chemistry, 2014-10, Vol.289 (40), p.27677-27691</ispartof><rights>2014 © 2014 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><rights>2014 by The American Society for Biochemistry and Molecular Biology, Inc.</rights><rights>2014 by The American Society for Biochemistry and Molecular Biology, Inc. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c509t-2a29d170cd6ecafa6dd09a97da00cabc4569c504700ce86b51e793b8992952f23</citedby><cites>FETCH-LOGICAL-c509t-2a29d170cd6ecafa6dd09a97da00cabc4569c504700ce86b51e793b8992952f23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183805/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183805/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25128526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arif, Mohammad</creatorcontrib><creatorcontrib>Wei, Jianshe</creatorcontrib><creatorcontrib>Zhang, Qi</creatorcontrib><creatorcontrib>Liu, Fei</creatorcontrib><creatorcontrib>Basurto-Islas, Gustavo</creatorcontrib><creatorcontrib>Grundke-Iqbal, Inge</creatorcontrib><creatorcontrib>Iqbal, Khalid</creatorcontrib><title>Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I2PP2A) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>Abnormal hyperphosphorylation of Tau leads to the formation of neurofibrillary tangles, a hallmark of Alzheimer disease (AD), and related tauopathies. The phosphorylation of Tau is regulated by protein phosphatase 2A (PP2A), which in turn is modulated by endogenous inhibitor 2 (I2PP2A). In AD brain, I2PP2A is translocated from neuronal nucleus to cytoplasm, where it inhibits PP2A activity and promotes abnormal phosphorylation of Tau. Here we describe the identification of a potential nuclear localization signal (NLS) in the C-terminal region of I2PP2A containing a conserved basic motif, 179RKR181, which is sufficient for directing its nuclear localization. The current study further presents an inducible cell model (Tet-Off system) of AD-type abnormal hyperphosphorylation of Tau by expressing I2PP2A in which the NLS was inactivated by 179RKR181 → AAA along with 168KR169 → AA mutations. In this model, the mutant NLS (mNLS)-I2PP2A (I2PP2AAA-AAA) was retained in the cell cytoplasm, where it physically interacted with PP2A and inhibited its activity. Inhibition of PP2A was associated with the abnormal hyperphosphorylation of Tau, which resulted in microtubule network instability and neurite outgrowth impairment. Expression of mNLS-I2PP2A activated CAMKII and GSK-3β, which are Tau kinases regulated by PP2A. The immunoprecipitation experiments showed the direct interaction of I2PP2A with PP2A and GSK-3β but not with CAMKII. Thus, the cell model provides insights into the nature of the potential NLS and the mechanistic relationship between I2PP2A-induced inhibition of PP2A and hyperphosphorylation of Tau that can be utilized to develop drugs preventing Tau pathology.</description><subject>Alzheimer Disease - genetics</subject><subject>Alzheimer Disease - metabolism</subject><subject>Brain - metabolism</subject><subject>Cell Nucleus - metabolism</subject><subject>Cytoplasm - genetics</subject><subject>Cytoplasm - metabolism</subject><subject>DNA-Binding Proteins</subject><subject>Glycogen Synthase Kinase 3 - genetics</subject><subject>Glycogen Synthase Kinase 3 - metabolism</subject><subject>Glycogen Synthase Kinase 3 beta</subject><subject>Histone Chaperones - genetics</subject><subject>Histone Chaperones - metabolism</subject><subject>Humans</subject><subject>Neurobiology</subject><subject>Nuclear Localization Signals</subject><subject>Phosphorylation</subject><subject>Protein Phosphatase 2 - genetics</subject><subject>Protein Phosphatase 2 - metabolism</subject><subject>tau Proteins - genetics</subject><subject>tau Proteins - metabolism</subject><subject>Transcription Factors - genetics</subject><subject>Transcription Factors - metabolism</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kcFv1SAcx4nRuOf07M1wnIe-AS1tuZg0L9O9ZGYvZkt2I5T-apm0VKBLnif_dJlvW_QwLgT48P3B74PQe0rWlFTF6W2r118pLda85DmvX6AVJXWe5ZzevEQrQhjNBOP1EXoTwi1JoxD0NTpinLKas3KFfm_20c1WhdFo_A0iTNG4Cbse77yLYCa8G1yYBxVVAMwavJ0G05roPGb4ZMt2O9Z8TJvdoiHgxv4awIzgM2t-AG7ayflRWXy-n8HPf4Oc31v1WONKLW_Rq17ZAO8e5mN0_fnsanOeXVx-2W6ai0xzImLGFBMdrYjuStCqV2XXEaFE1SlCtGp1wUuRyKJKS6jLllOoRN7WQjDBWc_yY_TpkDsv7QidTh_1ysrZm1H5vXTKyP9PJjPI7-5OFrTOa8JTwMlDgHc_FwhRjiZosFZN4JYgKa9LSlL7SUJPD6j2LgQP_VMZSuS9N5m8yXtv8uAt3fjw7-ue-EdRCRAHAFKP7gx4GbSBSUNnPOgoO2eeDf8DqKipRQ</recordid><startdate>20141003</startdate><enddate>20141003</enddate><creator>Arif, Mohammad</creator><creator>Wei, Jianshe</creator><creator>Zhang, Qi</creator><creator>Liu, Fei</creator><creator>Basurto-Islas, Gustavo</creator><creator>Grundke-Iqbal, Inge</creator><creator>Iqbal, Khalid</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20141003</creationdate><title>Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I2PP2A) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau</title><author>Arif, Mohammad ; Wei, Jianshe ; Zhang, Qi ; Liu, Fei ; Basurto-Islas, Gustavo ; Grundke-Iqbal, Inge ; Iqbal, Khalid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-2a29d170cd6ecafa6dd09a97da00cabc4569c504700ce86b51e793b8992952f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Alzheimer Disease - genetics</topic><topic>Alzheimer Disease - metabolism</topic><topic>Brain - metabolism</topic><topic>Cell Nucleus - metabolism</topic><topic>Cytoplasm - genetics</topic><topic>Cytoplasm - metabolism</topic><topic>DNA-Binding Proteins</topic><topic>Glycogen Synthase Kinase 3 - genetics</topic><topic>Glycogen Synthase Kinase 3 - metabolism</topic><topic>Glycogen Synthase Kinase 3 beta</topic><topic>Histone Chaperones - genetics</topic><topic>Histone Chaperones - metabolism</topic><topic>Humans</topic><topic>Neurobiology</topic><topic>Nuclear Localization Signals</topic><topic>Phosphorylation</topic><topic>Protein Phosphatase 2 - genetics</topic><topic>Protein Phosphatase 2 - metabolism</topic><topic>tau Proteins - genetics</topic><topic>tau Proteins - metabolism</topic><topic>Transcription Factors - genetics</topic><topic>Transcription Factors - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arif, Mohammad</creatorcontrib><creatorcontrib>Wei, Jianshe</creatorcontrib><creatorcontrib>Zhang, Qi</creatorcontrib><creatorcontrib>Liu, Fei</creatorcontrib><creatorcontrib>Basurto-Islas, Gustavo</creatorcontrib><creatorcontrib>Grundke-Iqbal, Inge</creatorcontrib><creatorcontrib>Iqbal, Khalid</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arif, Mohammad</au><au>Wei, Jianshe</au><au>Zhang, Qi</au><au>Liu, Fei</au><au>Basurto-Islas, Gustavo</au><au>Grundke-Iqbal, Inge</au><au>Iqbal, Khalid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I2PP2A) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>2014-10-03</date><risdate>2014</risdate><volume>289</volume><issue>40</issue><spage>27677</spage><epage>27691</epage><pages>27677-27691</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>Abnormal hyperphosphorylation of Tau leads to the formation of neurofibrillary tangles, a hallmark of Alzheimer disease (AD), and related tauopathies. The phosphorylation of Tau is regulated by protein phosphatase 2A (PP2A), which in turn is modulated by endogenous inhibitor 2 (I2PP2A). In AD brain, I2PP2A is translocated from neuronal nucleus to cytoplasm, where it inhibits PP2A activity and promotes abnormal phosphorylation of Tau. Here we describe the identification of a potential nuclear localization signal (NLS) in the C-terminal region of I2PP2A containing a conserved basic motif, 179RKR181, which is sufficient for directing its nuclear localization. The current study further presents an inducible cell model (Tet-Off system) of AD-type abnormal hyperphosphorylation of Tau by expressing I2PP2A in which the NLS was inactivated by 179RKR181 → AAA along with 168KR169 → AA mutations. In this model, the mutant NLS (mNLS)-I2PP2A (I2PP2AAA-AAA) was retained in the cell cytoplasm, where it physically interacted with PP2A and inhibited its activity. Inhibition of PP2A was associated with the abnormal hyperphosphorylation of Tau, which resulted in microtubule network instability and neurite outgrowth impairment. Expression of mNLS-I2PP2A activated CAMKII and GSK-3β, which are Tau kinases regulated by PP2A. The immunoprecipitation experiments showed the direct interaction of I2PP2A with PP2A and GSK-3β but not with CAMKII. Thus, the cell model provides insights into the nature of the potential NLS and the mechanistic relationship between I2PP2A-induced inhibition of PP2A and hyperphosphorylation of Tau that can be utilized to develop drugs preventing Tau pathology.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25128526</pmid><doi>10.1074/jbc.M114.565358</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 2014-10, Vol.289 (40), p.27677-27691
issn 0021-9258
1083-351X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4183805
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection
subjects Alzheimer Disease - genetics
Alzheimer Disease - metabolism
Brain - metabolism
Cell Nucleus - metabolism
Cytoplasm - genetics
Cytoplasm - metabolism
DNA-Binding Proteins
Glycogen Synthase Kinase 3 - genetics
Glycogen Synthase Kinase 3 - metabolism
Glycogen Synthase Kinase 3 beta
Histone Chaperones - genetics
Histone Chaperones - metabolism
Humans
Neurobiology
Nuclear Localization Signals
Phosphorylation
Protein Phosphatase 2 - genetics
Protein Phosphatase 2 - metabolism
tau Proteins - genetics
tau Proteins - metabolism
Transcription Factors - genetics
Transcription Factors - metabolism
title Cytoplasmic Retention of Protein Phosphatase 2A Inhibitor 2 (I2PP2A) Induces Alzheimer-like Abnormal Hyperphosphorylation of Tau
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T19%3A23%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytoplasmic%20Retention%20of%20Protein%20Phosphatase%202A%20Inhibitor%202%20(I2PP2A)%20Induces%20Alzheimer-like%20Abnormal%20Hyperphosphorylation%20of%20Tau&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Arif,%20Mohammad&rft.date=2014-10-03&rft.volume=289&rft.issue=40&rft.spage=27677&rft.epage=27691&rft.pages=27677-27691&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.M114.565358&rft_dat=%3Cproquest_pubme%3E1586101080%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1586101080&rft_id=info:pmid/25128526&rft_els_id=S0021925820484042&rfr_iscdi=true